Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.27 | 12.58 |
| PEG Ratio (TTM) | 1.03 | 1.13 |
| P/S Ratio (TTM) | 0.48 | 0.78 |
| P/B Ratio (TTM) | 0.72 | 1.17 |
| P/FCF Ratio (TTM) | -9.72 | -0.29 |
| Price to 5YR AVG Earnings Ratio | 8.96 | 7.09 |
| Price to 5YR AVG FCF Ratio | 12.29 | 7.74 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.81% | 6.51% |
| ROE (TTM) | 5.13% | 9.82% |
| Net Profit Margin (TTM) | 3.39% | 6.39% |
| ROIC 5YR AVG | 16.58% | 20.75% |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 38.58% | 49.70% | 10.57% |
| Revenue | -4.66% | 24.90% | 10.94% |
| Net Income | 39.17% | 73.08% | 23.03% |
| Cash Flow | 411.97% | 918.90% | 540.46% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.72 | 2.70 |
| Quick Ratio (TTM) | 1.14 | 1.55 |
| D/E Ratio (TTM) | 0.38 | 0.36 |
| Interest Coverage (TTM) | 14.97 | 36.54 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 2.12 | 3.61 |
| LTL to 5YR AVG FCF | 6.24 | 2.93 |
| Shares Outstanding Growth 5YR AVG | 6.13% | -3.23% |